3 November 2026 Sydney, Australia Quotation of New Options Nyrada Inc. (ASX:NYR), a clinical-stage biotechnology company focused on developing Transient Receptor Potential Canonical (TRPC) ion channel inhibitors to treat a range of medical conditions, is pleased to advise that the Company has...
Quotation of New Options
Filed with ASX · · 6 pages · English
Summary by 6ix AI
Nyrada, Inc. has filed a notice regarding the quotation of new options on the ASX, which will allow holders to exercise these options for CHESS Depositary Interests and additional Piggyback Options. Details about the top option holders and the distribution schedule are included in the filing to comply with ASX listing rules. The options have an exercise price and a defined exercise period, with further announcements regarding the ASX ticker to follow.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Story so far
Earlier from Nyrada
- Notice of Initial Substantial Holding - J Moore
- Update - Proposed issue of securities - NYR
- Change of Director's Interest Notice - JM
- Application for quotation of securities - NYR
- PROTECT-MI Phase IIa Clinical Trial Update No 4
Later from Nyrada
All Nyrada news releasesFollow Nyrada into a list and get an email when it puts out news.
Follow Nyrada